GDC-0941 Bimesylate
| CAS No. | 957054-33-0 | Cat. No. | BCP13802 |
| Name | GDC-0941 Bimesylate | ||
| Synonyms | GDC-0941 2 MeSO3H salt;Pictilisib dimethanesulfonate;GDC 0941 Bimesylate;GDC0941 Bimesylate; | ||
| Formula | C24H30N7O6S3 | M. Wt | 608.73 |
| Description | GDC-0941 is a potent, selective, orally bioavailable inhibitor of class I PI3 kinase for the treatment of cancer. GDC-0941 against p110a IC50=0.003μM,U87MG IC50=0.95μM, A2780 IC50=0.14 μM, and in vitro metabolic stability in mouse and human is 91.96%. The inhibitions of U87MG , PC3, MDA-MB-361 cancer cell proliferation are (IC50) 0.95, 0.28, 0.72 μM, respectively. | ||
| Pathways | PI3K/Akt/mTOR | ||
| Targets | PI3K | ||
Structure
Part data of this page collected from the open network resources, so Biochempartner can not guarantee its accuracy.
For product details of different batches, please contact our Customer
- Service & Tech Support:orders@biochempartner.com
- Website:www.biochempartner.com
Products are for research use only and not for human use. We do not sell to patients.